Condition: Asthma
Interventions: Drug: Low-Dose MK-8351; Drug: High-Dose MK-8351; Drug: Placebo to MK-8351
Sponsors: Merck; Merck
Not yet recruiting – verified August 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days